Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2022-09-20 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive 'Half-year Report' for EKF Diagnostics Holdings PLC for the period ended 30 June 2022. It contains detailed financial statements, operational highlights, a business review, and management commentary. It is not a mere announcement of a report (RPA) as it provides the full substantive financial data and analysis for the interim period. Therefore, it is classified as an Interim/Quarterly Report. H1 2022
2022-09-20 English
Notice of Interim Results & Investor Presentation
Report Publication Announcement Classification · 1% confidence The document explicitly states it is a "Notice of Interim Results & Investor Presentation." It announces when the interim results (which would typically be an IR or ER) will be released (September 20, 2022) and details a subsequent online presentation for investors regarding those results. Since the core purpose of this specific document is to announce the timing of the results release and the associated investor presentation, it fits the definition of a Report Publication Announcement (RPA). It is not the full Interim Report (IR) itself, nor is it the Earnings Release (ER) which contains the actual figures. It is an announcement about the publication of those reports and the accompanying investor event.
2022-09-01 English
Trading Update
Earnings Release Classification · 1% confidence The document is titled 'Trading Update' and provides unaudited financial performance metrics for the six months ended 30 June 2022 ('H1 2022'). It discusses revenues (£37.5m), adjusted EBITDA expectations, cash position, and operational progress across different business segments. Crucially, it states: 'EKF expects to announce its unaudited results for H1 2022 on 20 September 2022.' This indicates the document is a pre-results update summarizing performance for an interim period, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is a 'Trading Update,' its content is a comprehensive summary of interim financial performance, making IR the most appropriate classification over a simple Earnings Release (ER) which usually contains only key highlights, or an RPA which would only announce the upcoming results. H1 2022
2022-08-01 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1940 chars) and contains an 'RNS Number' (7003Q) and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of brief, time-sensitive regulatory update that doesn't fit into standard financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing (RNS), as it is distributed via the RNS system.
2022-06-29 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1923 characters) and contains an RNS Number (6993Q) and mentions 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading procedures, not a comprehensive financial report (like 10-K or IR) or a management/board change. Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory filing fallback category.
2022-06-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is identified by the header 'RNS Number : 5189Q' and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition/disposal of voting rights by Octopus Investments Limited, crossing a threshold. This type of mandatory disclosure concerning significant changes in share ownership is classified as a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.